Workflow
华盛昌(002980) - 2025年5月13日投资者关系活动记录表
CEMCEM(SZ:002980)2025-05-13 09:52

Financial Performance - In Q1 2025, the company achieved revenue of 40,369.1 million RMB, a year-on-year increase of 26.47% [2] - The net profit attributable to shareholders was 29,159.5 million RMB, reflecting a growth of 6.25% compared to the previous year [2] - Excluding the impact of share-based payments, the net profit attributable to shareholders was 37,633.9 million RMB, with a growth rate of 37.13% [2][3] Future Performance Goals - The company has set performance targets for 2024 to 2026, aiming for net profit or revenue growth rates of 25%, 50%, and 75% respectively compared to 2023 [3] - The management maintains a positive outlook for the 2025 performance assessment [3] Dividend Policy - The company is committed to a sustainable and stable profit distribution policy, adhering to legal requirements and considering shareholder interests [3] - The proposed dividend for 2024 is 7.3 RMB per 10 shares (tax included), with a capital reserve conversion of 4 additional shares for every 10 shares held [4] Growth Drivers - The company’s revenue for 2024 was 80,749.78 million RMB, a year-on-year increase of 20.55%, with a net profit of 13,842.49 million RMB, reflecting a growth of 29.21% [5] - Key growth factors include product structure optimization, increased revenue from proprietary brands, and a focus on large customer development strategies [6] Market Strategy - The company has diversified its global marketing strategy to mitigate risks associated with the U.S. market, maintaining stable operations and production capacity in Vietnam [8] - The medical diagnostics and life sciences analysis instruments segment is a strategic focus, with plans to integrate AI technology into existing products [9][11] R&D Investment - R&D investment has increased from 47.17 million RMB in 2020 to 90.45 million RMB in 2024, with a compound annual growth rate of 19.4% [13] - The focus areas for R&D include integrating large model technology into smart instruments and expanding the product matrix to align with international standards [13]